Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
grade A 49.08 -0.39% -0.19
ABT closed down 0.39 percent on Friday, June 23, 2017, on 1.32 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABT trend table...

Date Alert Name Type % Chg
Jun 23 NR7 Range Contraction 0.00%
Jun 22 New 52 Week High Bullish -0.39%
Jun 21 Slingshot Bullish Bullish Swing Setup 1.05%
Jun 20 New 52 Week High Bullish 0.64%
Jun 20 Shooting Star Candlestick Bearish 0.64%

Older signals for ABT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 49.59
52 Week Low 36.8304
Average Volume 7,077,841
200-Day Moving Average 42.1438
50-Day Moving Average 45.1546
20-Day Moving Average 47.235
10-Day Moving Average 48.318
Average True Range 0.6455
ADX 48.04
+DI 38.34
-DI: 9.17
Chandelier Exit (Long, 3 ATRs) 47.6535
Chandelier Exit (Short, 3 ATRs) 45.3365
Upper Bollinger Band 49.8397
Lower Bollinger Band 44.6303
Percent B (%b) 0.85
Bandwidth 0.110287
MACD Line 1.186
MACD Signal Line 1.0479
MACD Histogram 0.1381